Millie Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.2M Sell
30,682
-200
-0.6% -$22.6K 2.69% 11
2017
Q3
$4.5M Sell
30,882
-246
-0.8% -$33.5K 3.68% 6
2017
Q2
$4.04M Buy
31,128
+458
+1% +$56.1K 3.51% 6
2017
Q1
$3.82M Buy
30,670
+136
+0.4% +$16.3K 3.62% 6
2016
Q4
$3.53M Buy
30,534
+15,931
+109% +$1.77M 3.59% 5
2016
Q3
$1.53M Buy
14,603
+2,283
+19% +$247K 1.68% 25
2016
Q2
$1.22M Buy
12,320
+105
+0.9% +$10.9K 1.29% 30
2016
Q1
$1.22M Buy
12,215
+345
+3% +$35.5K 1.31% 33
2015
Q4
$1.42M Sell
11,870
-4,880
-29% -$565K 1.49% 32
2015
Q3
$1.81M Sell
16,750
-252
-1% -$31.3K 1.65% 28
2015
Q2
$1.97M Buy
17,002
+901
+6% +$103K 1.81% 26
2015
Q1
$1.86M Sell
16,101
-1,358
-8% -$162K 1.73% 26
2014
Q4
$1.95M Buy
+17,459
New +$1.84M 2.02% 22

Other funds holding CELG

Millie Capital Management's CELG Position: Q4 2017 in Review

Millie Capital Management reduced its Celgene Corp (CELG) stake by 0.65% in Q4 2017, selling an estimated $22.6K and leaving 30,682 shares worth $3.2M. The position accounts for 2.69% of the portfolio, ranked #11.

Millie Capital Management first reported a position in CELG in Q4 2014 and has held it in 13 quarters since. The position peaked at $4.5M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Millie Capital Management held 30,682 shares of Celgene Corp worth $3.2M as of Q4 2017.
  • Millie Capital Management sold 200 Celgene Corp shares in Q4 2017, an estimated $22.6K.
  • Celgene Corp made up 2.69% of Millie Capital Management's portfolio in Q4 2017, its #11 holding.
  • Millie Capital Management first reported a position in Celgene Corp in Q4 2014 and has held it in 13 quarters since.
  • Millie Capital Management's Celgene Corp position peaked at $4.5M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Millie Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.